Alnylam Pharmaceuticals
ALNY
#1123
Rank
$21.04 B
Marketcap
$157.11
Share price
3.61%
Change (1 day)
-64.43%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Number of shares outstanding for Alnylam Pharmaceuticals (ALNY)

Number of shares outstanding as of November 2026 : 133,828,000

According to Alnylam Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 133,828,000. At the end of 2024 the company had 126,138,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Alnylam Pharmaceuticals from 2003 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20240.12 B0.42%
20230.12 B1.9%
20220.12 B2.92%
20210.11 B3.01%
20200.11 B4.05%
20190.11 B10.57%
20180.10 B5.12%
201796.13 M11.99%
201685.84 M1.15%
201584.87 M10.28%
201476.95 M22.33%
201362.9 M21.4%
201251.82 M21.49%
201142.65 M1.26%
201042.12 M1%
200941.7 M1.24%
200841.19 M5.57%
200739.02 M21.49%
200632.12 M53.59%
200520.91 M7.21%
200419.5 M2209.85%
20030.84 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Novartis
NVS
1,896,000,000 1,316.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
2,400,000,000 1,693.35%๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
101,700,000-24.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
105,431,000-21.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
66,174,550-50.55%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
746,479,131 457.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1,166,000,000 771.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
143,378,000 7.14%๐Ÿ‡บ๐Ÿ‡ธ USA